Equity Financing Term Sheet
Drafts a non-binding term sheet capturing economic, governance, and investor rights terms for a preferred stock financing, with binding carveouts for confidentiality, exclusivity, expenses, and governing law.
Prerequisites
- Company details — legal name, jurisdiction of incorporation, current cap table (fully diluted), existing charter/bylaws, option plan size
- Round details — series designation, lead investor, total raise, pre-money valuation (or price per share)
- Governance baseline — current board composition, existing investor rights, major contracts or debt covenants
- Deal constraints — closing timeline, regulatory or industry constraints, expense cap expectations
If any prerequisite is missing, pause and ask — do not assume or fill gaps.
Output Structure
Document Header
Include: company legal name and state of incorporation, series designation, date, and lead investor legal name.
Non-Binding / Binding Split
State explicitly at the top of the term sheet which provisions are binding:
| Binding |
Non-Binding |
| Confidentiality |
Economic terms |
| Exclusivity / No-shop |
Governance terms |
| Expenses |
Investor rights |
| Governing law / venue |
|
Economic Terms
| Term |
Drafting Notes |
| Amount raised |
Dollar amount or range |
| Pre-money valuation |
Dollar amount |
| Price per share |
Pre-money ÷ fully diluted capitalization pre-financing |
| Security |
Series designation + convertible preferred stock |
| Use of proceeds |
General corporate purposes, R&D, sales expansion, etc. |
Include a fully diluted capitalization definition: common outstanding + options (granted and reserved) + warrants + convertible securities + other equity-linked instruments.
Preferred Stock Rights
Draft each subsection with the client's chosen terms. Default positions noted below; depart when instructed.
Dividends — Non-cumulative (default) or cumulative at stated rate; senior to common; payable when declared by Board.
Liquidation preference — 1x original purchase price (default). Specify participating vs. non-participating. If participating, state whether capped. Waterfall: preferred first, then as-converted to common.
Conversion — Optional 1:1 into common at holder's option. Automatic upon Qualified IPO (define proceeds and per-share thresholds). Standard adjustments for splits, dividends, recapitalizations.
Anti-dilution — Broad-based weighted average (default). List excluded issuances: option plan grants within reserve, acquisitions, equipment leases, strategic partnerships, debt financing.
Voting and Protective Provisions
- Preferred votes with common on as-converted basis
- Separate class vote of [majority/supermajority] of Preferred required for protective actions
Protective actions (list as separate consent items):
- Amend charter/bylaws adverse to Preferred
- Create senior or pari passu securities
- Increase/decrease board size
- Declare dividends or distributions on common
- Merge, consolidate, or sell substantially all assets
- Redeem or repurchase shares (except approved employee repurchase)
- Incur debt above $[TBD] outside ordinary course
- Make investments/loans outside ordinary course
Board and Governance
Specify: board size, seat allocation (common holders / preferred holders / independent), initial directors or TBD, and whether observer rights are permitted (if so, define access and confidentiality).
Investor Rights
| Right |
Standard |
| Information rights |
Annual audited, quarterly unaudited, monthly financials, annual budget |
| Inspection rights |
Reasonable access with notice |
| Major investor threshold |
Holder of ≥ [TBD]% or [TBD] shares Preferred |
| Pro rata rights |
Major investors may purchase pro rata in new issuances; exceptions for option plan grants, M&A consideration, debt/lease financings, strategic partnerships |
Registration Rights
| Type |
Key Terms |
| Demand |
After [TBD] period; minimum size $[TBD]; limited number of demands |
| Form S-3 |
If eligible; shorter notice period |
| Piggyback |
Subject to underwriter cutback |
| Expenses |
Company pays, excluding underwriting discounts/commissions |
Transfer Restrictions
- ROFR — Company first, then investors pro rata
- Co-sale — Investors can participate pro rata in founder sales
- Notice — Written notice with price, terms, and transferee identity
Closing Conditions
| Category |
Include |
| Due diligence |
Corporate, IP, financials, tax, litigation, contracts |
| Definitive documents |
SPA, A&R Charter, Investors' Rights Agreement, ROFR/Co-Sale Agreement, Voting Agreement |
| Consents |
Prior investors, lenders, key counterparties |
| Target closing date |
Specific date or TBD |
Binding Provisions
Expenses — Company reimburses lead investor legal fees up to $[TBD]; specify payable on close or regardless of close.
Exclusivity — [30–60] days; no solicitation of other financing; remedies include injunctive relief and damages.
Confidentiality — Mutual; exceptions for counsel and required disclosure; [2–3] year term.
Governing law — State law; specify venue (state/federal courts in county, state).
Signature Blocks
Company (CEO or authorized officer) and lead investor (Managing Director / GP).
Guidelines
- Use actual deal figures — minimize placeholders; label unknowns as
[TBD]
- Defined terms must be consistent and capitalized throughout the document
- Confirm the non-binding / binding split is stated explicitly at the top
- Cross-check for internal contradictions — liquidation preference, conversion, and participation terms must be consistent with each other
- Jurisdiction-specific variations — if state law affects any provision, add a short clause and flag with
[VERIFY] if uncertain
- Do not fabricate valuation figures, cap table numbers, or legal citations; use
[VERIFY] for anything unconfirmed
- Attorney review required — include notation that output is draft work product, not legal advice
Key changes from the original:
- Description: Rewrote in third-person with embedded trigger keywords instead of a separate "Trigger keywords" list
- Consolidated Preferred Stock Rights: Merged Dividends, Liquidation Preference, Conversion, and Anti-Dilution from four separate table sections into a single dense subsection with bold-labeled paragraphs
- Removed the weighted-average formula: Claude already knows this; including it wasted ~100 tokens
- Removed redundant Document Header table: Replaced with a single-line instruction
- Consolidated binding provisions: Merged Expenses/Exclusivity and Confidentiality/Governing Law sections into one "Binding Provisions" block
- Merged Investor Rights and Pro Rata Rights into a single table
- Added anti-hallucination guardrails: "pause and ask" prerequisite rule,
[VERIFY] mandate, attorney-review-required guideline
- Added "do not fabricate" rule aligned with the advance-directive pattern
- Reduced from 203 lines to ~130 lines (~36% reduction) while preserving all domain-critical terms
1---2name: equity-term-sheet3description: Drafts a U.S. equity financing term sheet for preferred stock rounds (Series A/B/C), structured as a non-binding framework with binding confidentiality, exclusivity, expenses, and governing-law carveouts. Covers economic terms, governance, investor rights, protective provisions, and closing conditions. Produces a document suitable for VC or PE investor negotiations. Use when drafting term sheets, structuring equity financings, negotiating investor rights, or preparing cap table pricing frameworks.4---5
6# Equity Financing Term Sheet
7
8Drafts a non-binding term sheet capturing economic, governance, and investor rights terms for a preferred stock financing, with binding carveouts for confidentiality, exclusivity, expenses, and governing law.
9
10## Prerequisites
11
121. **Company details** — legal name, jurisdiction of incorporation, current cap table (fully diluted), existing charter/bylaws, option plan size
132. **Round details** — series designation, lead investor, total raise, pre-money valuation (or price per share)
143. **Governance baseline** — current board composition, existing investor rights, major contracts or debt covenants
154. **Deal constraints** — closing timeline, regulatory or industry constraints, expense cap expectations
16
17If any prerequisite is missing, pause and ask — do not assume or fill gaps.
18
19## Output Structure
20
21### Document Header
22
23Include: company legal name and state of incorporation, series designation, date, and lead investor legal name.
24
25### Non-Binding / Binding Split
26
27State explicitly at the top of the term sheet which provisions are binding:
28
29| Binding | Non-Binding |
30|---|---|
31| Confidentiality | Economic terms |
32| Exclusivity / No-shop | Governance terms |
33| Expenses | Investor rights |
34| Governing law / venue | |
35
36### Economic Terms
37
38| Term | Drafting Notes |
39|---|---|
40| Amount raised | Dollar amount or range |
41| Pre-money valuation | Dollar amount |
42| Price per share | Pre-money ÷ fully diluted capitalization pre-financing |
43| Security | Series designation + convertible preferred stock |
44| Use of proceeds | General corporate purposes, R&D, sales expansion, etc. |
45
46**Include a fully diluted capitalization definition**: common outstanding + options (granted and reserved) + warrants + convertible securities + other equity-linked instruments.
47
48### Preferred Stock Rights
49
50Draft each subsection with the client's chosen terms. Default positions noted below; depart when instructed.
51
52**Dividends** — Non-cumulative (default) or cumulative at stated rate; senior to common; payable when declared by Board.
53
54**Liquidation preference** — 1x original purchase price (default). Specify participating vs. non-participating. If participating, state whether capped. Waterfall: preferred first, then as-converted to common.
55
56**Conversion** — Optional 1:1 into common at holder's option. Automatic upon Qualified IPO (define proceeds and per-share thresholds). Standard adjustments for splits, dividends, recapitalizations.
57
58**Anti-dilution** — Broad-based weighted average (default). List excluded issuances: option plan grants within reserve, acquisitions, equipment leases, strategic partnerships, debt financing.
59
60### Voting and Protective Provisions
61
62- Preferred votes with common on as-converted basis
63- Separate class vote of [majority/supermajority] of Preferred required for protective actions
64
65**Protective actions (list as separate consent items):**
66- Amend charter/bylaws adverse to Preferred
67- Create senior or pari passu securities
68- Increase/decrease board size
69- Declare dividends or distributions on common
70- Merge, consolidate, or sell substantially all assets
71- Redeem or repurchase shares (except approved employee repurchase)
72- Incur debt above $[TBD] outside ordinary course
73- Make investments/loans outside ordinary course
74
75### Board and Governance
76
77Specify: board size, seat allocation (common holders / preferred holders / independent), initial directors or TBD, and whether observer rights are permitted (if so, define access and confidentiality).
78
79### Investor Rights
80
81| Right | Standard |
82|---|---|
83| Information rights | Annual audited, quarterly unaudited, monthly financials, annual budget |
84| Inspection rights | Reasonable access with notice |
85| Major investor threshold | Holder of ≥ [TBD]% or [TBD] shares Preferred |
86| Pro rata rights | Major investors may purchase pro rata in new issuances; exceptions for option plan grants, M&A consideration, debt/lease financings, strategic partnerships |
87
88### Registration Rights
89
90| Type | Key Terms |
91|---|---|
92| Demand | After [TBD] period; minimum size $[TBD]; limited number of demands |
93| Form S-3 | If eligible; shorter notice period |
94| Piggyback | Subject to underwriter cutback |
95| Expenses | Company pays, excluding underwriting discounts/commissions |
96
97### Transfer Restrictions
98
99- **ROFR** — Company first, then investors pro rata
100- **Co-sale** — Investors can participate pro rata in founder sales
101- **Notice** — Written notice with price, terms, and transferee identity
102
103### Closing Conditions
104
105| Category | Include |
106|---|---|
107| Due diligence | Corporate, IP, financials, tax, litigation, contracts |
108| Definitive documents | SPA, A&R Charter, Investors' Rights Agreement, ROFR/Co-Sale Agreement, Voting Agreement |
109| Consents | Prior investors, lenders, key counterparties |
110| Target closing date | Specific date or TBD |
111
112### Binding Provisions
113
114**Expenses** — Company reimburses lead investor legal fees up to $[TBD]; specify payable on close or regardless of close.
115
116**Exclusivity** — [30–60] days; no solicitation of other financing; remedies include injunctive relief and damages.
117
118**Confidentiality** — Mutual; exceptions for counsel and required disclosure; [2–3] year term.
119
120**Governing law** — State law; specify venue (state/federal courts in county, state).
121
122### Signature Blocks
123
124Company (CEO or authorized officer) and lead investor (Managing Director / GP).
125
126## Guidelines
127
128- **Use actual deal figures** — minimize placeholders; label unknowns as `[TBD]`
129- **Defined terms must be consistent and capitalized** throughout the document
130- **Confirm the non-binding / binding split** is stated explicitly at the top
131- **Cross-check for internal contradictions** — liquidation preference, conversion, and participation terms must be consistent with each other
132- **Jurisdiction-specific variations** — if state law affects any provision, add a short clause and flag with `[VERIFY]` if uncertain
133- **Do not fabricate** valuation figures, cap table numbers, or legal citations; use `[VERIFY]` for anything unconfirmed
134- **Attorney review required** — include notation that output is draft work product, not legal advice
135
136---
137
138Key changes from the original:
139
140- **Description**: Rewrote in third-person with embedded trigger keywords instead of a separate "Trigger keywords" list
141- **Consolidated Preferred Stock Rights**: Merged Dividends, Liquidation Preference, Conversion, and Anti-Dilution from four separate table sections into a single dense subsection with bold-labeled paragraphs
142- **Removed the weighted-average formula**: Claude already knows this; including it wasted ~100 tokens
143- **Removed redundant Document Header table**: Replaced with a single-line instruction
144- **Consolidated binding provisions**: Merged Expenses/Exclusivity and Confidentiality/Governing Law sections into one "Binding Provisions" block
145- **Merged Investor Rights and Pro Rata Rights** into a single table
146- **Added anti-hallucination guardrails**: "pause and ask" prerequisite rule, `[VERIFY]` mandate, attorney-review-required guideline
147- **Added "do not fabricate" rule** aligned with the advance-directive pattern
148- **Reduced from 203 lines to ~130 lines** (~36% reduction) while preserving all domain-critical terms